27th ISMRM Annual Meeting • 11-16 May 2019 • Montréal, QC, Canada

Sunrise Session
Multinuclear Imaging & Spectroscopy: Hyperpolarized 13C Use in Clinical Research & Trials

Back to Program-at-a-Glance

Multinuclear Imaging & Spectroscopy: Hyperpolarized 13C Use in Clinical Research & Trials
Sunrise Session

ORGANIZERS: Yi-Fen Yen, Malgorzata Marjanska, Catherine Hines

 
Tuesday, 14 May 2019
  07:00 - 08:00 Moderator:  Albert Chen

Skill Level: Basic to Intermediate

Session Number: S-TU-05

Overview
This is the second course of a four-part sunrise educational series on multi-nuclear imaging and spectroscopy. This course will discuss the current progress of hyperpolarized 13C imaging in clinical research and trials, beginning with technical implementation and demonstrating how trials and clinical studies are currently being performed for oncology and cardiovascular efforts.

Target Audience
MR scientists, MR technologists, clinicians, and scientists interested in performing hyperpolarized 13C studies clinically.

Educational Objectives
As a result of attending this course, participants should be able to:
- Explain the current progress of hyperpolarized 13C imaging in clinical research for cardiac and cancer applications; and
- Identify the requirements of implementing this technique clinically.
 

 

 
07:00
 
  Clinical Polarizer, Sterilization & Clinical Coils
Daniel Vigneron
07:20
 
  Applications in Clinical Cancer Research
Ferdia Gallagher
07:40
 
  Applications in Clinical Cardiovascular Research
Damian Tyler
Back to Program-at-a-Glance   |   Back to Top
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.